Aldosterone Antagonism and Microvascular Function
Effects of Aldosterone Antagonism on Insulin-mediated Microvascular Function in Subjects With the Metabolic Syndrome
Sponsor: Maastricht University Medical Center
Terminated
Failure to recruit sufficient participants
Other terminated trials from Maastricht University Medical Center
- Atrophy, Muscle · Feb 2026
- Deep Sedation · Phase NA · Nov 2024
- Covid19 · Aug 2024
- Functional Dyspepsia · Phase PHASE3 · Aug 2024
- Healthy · May 2024
See all terminations from Maastricht University Medical Center
Listed as NCT01887119, this PHASE4 trial focuses on Abdominal Obesity Metabolic Syndrome and Hypertension and remains terminated or withdrawn. Sponsored by Maastricht University Medical Center, it has been updated 9 times since 2013, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE4
-
Jan 2021 — Jul 2024 [monthly]
Terminated PHASE4
-
Dec 2018 — Jan 2021 [monthly]
Terminated PHASE4
Status: Recruiting → Terminated
-
Nov 2018 — Dec 2018 [monthly]
Recruiting PHASE4
▶ Show 4 earlier versions
-
Jun 2018 — Nov 2018 [monthly]
Recruiting PHASE4
-
Jun 2017 — Jun 2018 [monthly]
Recruiting PHASE4
-
Feb 2017 — Jun 2017 [monthly]
Recruiting PHASE4
-
Jan 2017 — Feb 2017 [monthly]
Recruiting PHASE4
First recorded
Oct 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Maastricht University Medical Center
For direct contact, visit the study record on ClinicalTrials.gov .